Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Huldrych F. Guenthard"'
Autor:
Manuel Battegay, Huldrych F. Guenthard, Enos Bernasconi, Axel J. Schmidt, Jan A Roth, Roger D. Kouyos, Viacheslav Kachalov, Patrick Schmid, Suraj Balakrishna, Katharina Kusejko, Matthias Cavassini, Dunja Nicca, Maria Christine Thurnheer, Luisa Salazar-Vizcaya, Andri Rauch
BackgroundOver the last decade, syphilis diagnoses among men-who-have-sex-with-men (MSM) have strongly increased in Europe. Understanding the drivers of the ongoing epidemic may aid to curb transmissions.Methods and FindingsWe set up an epidemiologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f3b677f4f1b3ad054e3557f44afe3de
https://doi.org/10.1101/2021.01.20.21250179
https://doi.org/10.1101/2021.01.20.21250179
Autor:
Maroussia Roelens, Michael J. Crowther, Caroline E. Weibull, Torsten Hothorn, Olivia Keiser, Huldrych F. Guenthard, Matthias Bopp
Objective Severity of the coronavirus disease 2019 (covid-19) has been previously reported in terms of absolute mortality in SARS-CoV-2 positive cohorts. An assessment of mortality relative to mortality in the general population is presented. Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337b51f0f38f0250861a25e8b223d3be
https://doi.org/10.1101/2020.06.10.20127670
https://doi.org/10.1101/2020.06.10.20127670
Autor:
Karin J Metzner, Christine Leemann, Francesca Di Giallonardo, Christina Grube, Alexandra U Scherrer, Dominique Braun, Herbert Kuster, Rainer Weber, Huldrych F Guenthard
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21734 (2011)
In the Zurich Primary HIV infection study (ZPHI), minority drug-resistant HIV-1 variants were detected in some acutely HIV-1-infected patients prior to initiation of early antiretroviral therapy (ART). Here, we investigated the reappearance of minori
Externí odkaz:
https://doaj.org/article/f6fab6212d234b988ecc8e22b23a5590
Autor:
Herbert Kuster, Rainer Weber, Alexandra U. Scherrer, Huldrych F. Guenthard, Christine Leemann, Karin J. Metzner, Dominique L Braun, Christina Grube, Francesca Di Giallonardo
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21734 (2011)
PLoS ONE; Vol 6
PLoS ONE
PloS one
PLoS ONE; Vol 6
PLoS ONE
PloS one
Background In the Zurich Primary HIV infection study (ZPHI), minority drug-resistant HIV-1 variants were detected in some acutely HIV-1-infected patients prior to initiation of early antiretroviral therapy (ART). Here, we investigated the reappearanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a54165d1ba1b32375119a6af2cfb780
http://europepmc.org/articles/PMC3130779?pdf=render
http://europepmc.org/articles/PMC3130779?pdf=render
Autor:
James Young, Pietro Vernazza, Huldrych F. Guenthard, Heiner C. Bucher, Christoph A Fux, Enos Bernasconi, Matthias Cavassini, Martin Rickenbach, Bernard Hirschel, Manuel Battegay
Publikováno v:
Antiviral Therapy, Vol. 14, No 6 (2009) pp. 771-779
Background Efavirenz and lopinavir boosted with ritonavir are both recommended as first-line therapies for patients with HIV when combined with two nucleoside reverse transcriptase inhibitors. It is uncertain which therapy is more effective for patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70445a6ba1e1fd9b2d76126c8725d007
https://pubmed.ncbi.nlm.nih.gov/19812439
https://pubmed.ncbi.nlm.nih.gov/19812439